NCT03233412View on ClinicalTrials.gov

Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

January 14, 2020

Study Completion Date

January 14, 2020

Conditions
High Grade Intraepithelial NeoplasiaCervix Cancer
Interventions
PROCEDURE

Control

Exertion of the cervix transformation zone

DRUG

Imiquimod

Application by the doctor of immunomodulatory cream on the uterine cervix 1 time per week for 12 weeks

Trial Locations (1)

Unknown

Barretos Cancer Hospital, Barretos

All Listed Sponsors
collaborator

Farmoquimica S.A.

INDUSTRY

lead

Barretos Cancer Hospital

OTHER

NCT03233412 - Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions | Biotech Hunter | Biotech Hunter